Elder Pharmaceuticals Ltd

Elder Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Elder Pharmaceuticals Ltd

₹ 38.0 4.97%
12 Sep 2016
elderindia.com
About

Elder Pharmaceuticals Limited, incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in deals in pharmaceuticals & related products

[ add key points ]
Website
  • Market Cap ₹ 78.0 Cr.
  • Current Price ₹ 38.0
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 324
  • Dividend Yield 0.00 %
  • ROCE -4.78 %
  • ROE -44.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.12 times its book value
  • Debtor days have improved from 90.0 to 65.4 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -5.33% over past five years.
  • Company has a low return on equity of -7.47% over last 3 years.
  • Contingent liabilities of Rs.161 Cr.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
231 189 153 138 102 91 84 36 24
190 131 113 111 115 613 110 67 47
Operating Profit 40 58 41 27 -13 -522 -26 -32 -23
OPM % 17% 31% 26% 19% -13% -575% -30% -89% -94%
10 0 5 2 12 756 8 1 1
Interest 20 44 34 43 66 118 20 35 22
Depreciation 7 7 7 7 7 7 9 7 8
Profit before tax 23 7 5 -21 -75 110 -47 -73 -51
Tax % 20% 0% 20% 0% 0% 1% 0% 0% 0%
18 7 4 -21 -75 109 -47 -73 -51
EPS in Rs 8.98 3.30 1.87 -10.41 -36.66 53.09 -22.85 -35.54 -24.94
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 15m Jun 2014 TTM
355 449 551 620 703 833 979 1,217 471 235
294 371 446 520 578 657 776 949 916 837
Operating Profit 61 78 105 100 125 176 202 268 -445 -602
OPM % 17% 17% 19% 16% 18% 21% 21% 22% -94% -256%
6 7 8 7 7 3 18 22 752 766
Interest 14 16 24 37 51 63 89 138 260 195
Depreciation 6 9 11 12 17 27 28 37 29 31
Profit before tax 47 61 79 59 65 89 104 116 18 -61
Tax % 22% 19% 11% 16% 14% 21% 19% 19% 56%
37 49 70 49 55 71 84 94 8 -62
EPS in Rs 26.51 37.09 26.06 29.37 34.47 40.94 45.64 3.86 -30.24
Dividend Payout % 12% 9% 7% 10% 10% 9% 7% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: -5%
3 Years: -17%
TTM: -60%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -413%
Stock Price CAGR
10 Years: 1%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: -1%
3 Years: -7%
Last Year: -45%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Equity Capital 18 19 19 19 19 21 21 21 21
Reserves 238 305 366 396 456 591 671 757 765
198 237 342 400 556 749 884 1,138 598
97 113 91 118 125 140 138 292 552
Total Liabilities 551 673 818 934 1,155 1,500 1,714 2,208 1,936
90 140 169 171 465 476 508 484 435
CWIP 95 137 163 252 66 93 191 268 304
Investments 43 38 62 4 20 11 21 4 4
323 358 423 507 604 920 995 1,452 1,193
Total Assets 551 673 818 934 1,155 1,500 1,714 2,208 1,936

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
-5 71 -37 62 9 62 19 -32 1,153
-89 -89 -82 -38 -137 -47 -145 -48 -15
82 38 130 -28 142 160 3 39 -688
Net Cash Flow -12 20 10 -3 14 174 -122 -42 451
Free Cash Flow -102 -30 -103 -40 -115 -3 -138 -122 1,125
CFO/OP 10% 105% -27% 72% 16% 46% 20% -3% -261%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2006 Mar 2007 Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Jun 2013 Jun 2014
Debtor Days 111 99 92 105 100 99 106 98 65
Inventory Days 219 154 115 107 157 183 171 101 33
Days Payable 60 65 45 39 42 44 34 43 40
Cash Conversion Cycle 270 189 162 172 216 239 243 157 58
Working Capital Days 200 158 179 194 211 139 167 100 -276
ROCE % 15% 16% 13% 13% 13% 14% 15% -5%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports